Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3591_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
89 Мб
Скачать
306
V. Kubihal et al.
anastomotic vessels. Pulmonary embolization following UAE is rare. Death following UAE is reported in less than 1in 1000 patients, commonly due to uterine infection and sepsis or pulmonary embolism [1, 2].
25.2.8 Outcome
Randomized control trial by Mara et al. showed that at 6months follow-up, UAE had similar improvement in symp­toms, quality of life, and ovarian function, when compared to myomectomy. However, the same group at a 2-year follow­ up reported that pregnancy rate was better following myo­mectomy (78%) compared to UAE (50%) [5, 6]. Systematic review of 7 RCTs and 793 patients by Gupta etal., which included study by Mara et al., suggested that evidence of higher fertility rate in myomectomy group over UAE is low quality evidence, and should be considered with caution. The study also reported that there is no statistically signicant difference between UAE and myomectomy in patient satis­faction and major complications rate; however, UAE had higher minor complications rate and increased chance of requirement of surgical intervention in two to ve years fol­lowing UAE [7]. Systematic review by Zhang etal. included 84 studies. Six studies showed that in up to 95% of patients, myomectomy was associated with signicant decrease in bleeding related symptoms. Forty-one studies on UAE showed that 79 to 98.5% of patients had signicant decrease bleeding bleeding-related symptoms following UAE.Three studies suggested that UAE may be better than myomectomy in control of broid-related bleeding [8].
Systematic review by Popovic etal. (2011) which included
15 studies, and 511 patients, showed aggregate symptomatic improvement in 75% of patients with adenomyosis [9]. Metanalysis by de Bruijn etal. (2017) showed symptomatic improvement in 83.1% of patients [10].
In patients with postpartum hemorrhage, technical suc-
cess rate of UAE approaches 100%, and UAE is effective in ~86–96% of patients with postpartum hemorrhage [4, 11]. Patients with prior UAE for postpartum hemorrhage is asso­ciated with increased risk of abnormal placentation, and postpartum hemorrhage in next pregnancy [12].
Systematic review by Yang etal. included 16 studies and
421 patients, which showed that in patients with abnormal placentation, UAE was associated with signicant reduction in intraoperative blood loss during cesarean delivery or cesarean hysterectomy. Requirement of emergent hysterec­tomy was also signicantly decreased following UAE with cumulative rate of 19.6%. Incidence of major complications was low; however, there was no signicant decrease in the length of hospital stay [13].
Systematic review by Fowler et al. which included 204
studies, and 454 patients with cervical ectopic pregnancy,
showed that in comparison with methotrexate alone, dilata­tion and curettage alone (odds ratio—2.26) or with UAE (odds ratio—4.85), and UAE alone (odds ratio—0.17) showed more effective results [14].

25.3 Prostatic Artery Embolization (PAE)

Benign prostatic hyperplasia (BPH) is characterized by benign enlargement of transitional zone of prostate gland, which can cause bladder outlet obstruction and lower urinary tract symp­toms (LUTS). BPH is more common in elderly men, with up to 80% of men above 70years of age having lower urinary tract symptoms secondary to BPH [15, 16]. Medical manage­ment is the rst line of treatment for mild to moderate symp­toms. Surgery such as transurethral resection of prostate and open prostatectomy is indicated when medical management fails or is contraindicated. However, surgery can be associated with considerable morbidity such as major bleeding, erectile dysfunction, ejaculatory dysfunction, urinary incontinence, urethral stricture, urinary retention, and urinary tract infection. Prostatic artery embolization (PAE) offers minimally invasive alternative to surgery in patients with BPH (Fig.25.2) [15]. PAE is a safe and effective procedure and avoids complica­tions associated with surgery such as erectile dysfunction, ret­rograde ejaculation, and urinary incontinence [16].
Fig. 25.2 Schematic diagram of prostatic artery embolization. The enlarged prostate is supplied by tortuous hypertrophied prostatic artery
25 Interventions ofthePelvic Vessels
307
25.3.1 Rationale Behind PAE
• Prostate artery embolization causes ischemic shrinkage of prostatic gland and subsequent improvement in lower uri­nary tract symptoms.
• Following PAE, level of intra-prostatic testosterone and its highly active metabolite dihydrotestosterone decreases.
• There is also a reduction of alpha 1 androgenic receptor in the prostate gland, following PAE, which results in the relaxation of prostatic smooth muscles.
25.3.2 Indications [17, 18]
• BPH with moderate to severe LUTS refractory to medical treatment, or intolerance to medical treatment
• Patients with prostate volume >65ml as an alternative to surgery
• Contraindication to surgery or patient’s refusal of surgery
• Long waiting time for surgery
• Sexually active men (to avoid risk of retrograde ejaculation)
• Urinary retention with indwelling Foley’s catheter
• Hematuria of prostatic origin
25.3.5 Clinical Assessment
International Prostate Symptom Score (IPSS) is the gold stan­dard for assessing severity of symptoms of BPH.It includes seven questions regarding symptoms related to BPH, such as incomplete emptying, frequency, intermittency, urgency, weak stream, straining, and nocturia, that are scored from 0 to 5 bases on severity of the symptom. Total score of 0 to 7 sug­gests mild disease, score 8 to 19 suggests moderate disease, and score of 20 or more suggests severe disease. IPSS is also useful in monitoring improvement after PAE.
Quality of Life (QoL) questionnaire asks patients with BPH to rate from 0 to 6 on how would they feel if they had to live the rest of their life with current symptoms, where 0 suggests delighted and 6 suggests terrible. It is useful for patient selection, and also follow-up following intervention.
International Index of Erectile Function (IIEF) is the sum of ve questions, which are scored from 0 to 5. Lower score indicates more severe perceived erectile dysfunction. It is useful in assessing the effect of BPH treatment on erectile function [16, 18].
25.3.6 Urodynamic Testing, andPost-Void
Residual (PVR) Urine
25.3.3 Contraindications [18]
• Urinary tract infection
• Prostate cancer
• Urethral stricture
• Large bladder diverticulum
• Neurogenic bladder
• Severe atherosclerosis
• Renal insufciency
25.3.4 Preprocedural Evaluation [17]
Clinical Assessment
• IPSS—International Prostate Symptom Score
• IIEF—International Index of Erectile Dysfunction
• QoL (Quality of Life) questionnaire
Urodynamic Study and Laboratory Evaluation
• Urodynamic testing
• Complete hemogram, Renal function test, Coagulation parameters, Serum PSA, Urine analysis
Imaging
• Ultrasound prostate, Urinary bladder and kidneys
• Pelvic CT angiography
• MRI prostate and MR angiography
Uroowmetry and PVR offer objective assessment of blad­der outlet obstruction before intervention. Volume of at least 150ml of voided urine is necessary for accurate assessment during uroowmetry. Uroowmetry measures voided vol­ume, maximum ow rate, average ow rate, time to maxi­mum, and ow time. Maximum ow rate of less than or equal to 15ml/s is a requirement for prostatic artery emboli­zation. PVR is measured on ultrasonography or by catheter­ization of bladder. PVR of more than 300ml suggests chronic bladder outlet obstruction [16, 18].
25.3.7 Imaging
25.3.7.1 Ultrasonography (USG)
Transabdominal or transrectal USG can be performed. Prostate volume is measured. PAE is generally recommended when prostate size is greater than 30–40ml. Post void residual urine is measured to assess severity of bladder outlet obstruction. Kidney, and urinary bladder are also evaluated. Ultrasound elas­tography is newer technique that can be used assess the degree of stiffness in transitional zone of the prostate, which correlates well with the severity of bladder outlet obstruction [16, 17].
25.3.7.2 Computed Tomography (CT)
CT is not routinely used for preprocedural evaluation before PAE.CT angiography can be used to assess relevant pelvic
308
V. Kubihal et al.
vascular anatomy. It may be useful to assess severity of ath­erosclerosis before PAE.Disadvantages of CT include poor soft tissue resolution, and limited parenchymal evaluation, radiation exposure, and requirement of intravenous iodinated contrast [17].
25.3.7.3 Magnetic Resonance Imaging (MRI)
MRI has a better soft tissue resolution and allows excellent assessment of prostate parenchyma. Preprocedural evalua­tion of prostate volume, prostate zonal volume index, and intravesical protrusion of prostate gland is better appreciated with MRI.Prostate zonal volume index is a ratio calculated by dividing central gland volume by whole prostate volume. Preprocedural prostate zonal volume index correlates well with degree of clinical improvement following PAE.Baseline value of more than 0.45 is associated with better clinical out­come following PAE, with sensitivity of 85% and specicity of 75%. MRI is also useful to rule out other causes of bladder outlet obstruction and prostate cancer.
MR angiography can be used for preprocedural evalua-
tion of pelvic vasculature. Preprocedural knowledge of vas­cular anatomy and prostatic artery origin can reduce the number of digital subtraction angiography (DSA) runs and therefore reduce radiation dose, contrast volume, and proce­dure time [17].
25.3.8 Requirements forProstatic Artery
Embolization [17, 18]
• Prostate volume: >30–40ml.
• IPSS: 18.
• QoL: 3.
• Maximum urine ow rate: 15ml/s.
• IIEF and PVR are only used for monitoring purpose.
25.3.9 Relevant Vascular Anatomy
Detailed knowledge of patient’s pelvic arterial anatomy is necessary for safe and effective PAE.BPH arises from cen­tral gland (transitional zone) of the prostate, and arterials supplying the central gland are the primary target in PAE.
Internal iliac artery has two major divisions, namely,
anterior and posterior division, which supply visceral branches and parietal branches. Posterior division gives three branches, namely, iliolumbar artery, lateral sacral arteries, and superior gluteal artery. Anterior division of the internal iliac artery gives origin to superior vesical artery, inferior vesical artery / prostatic artery, obturator artery, middle rectal artery, internal pudendal artery, and inferior gluteal artery. Acronym PROVISO (internal Pudendal artery, middle Rectal artery, Obturator artery, Inferior
Vesical artery (prostatic artery), and Superior vesical artery under Oblique view) is used to remember medial branches of the anterior division of internal iliac artery under ipsilat­eral oblique angiogram [16, 17].
Prostatic artery that supplies the prostate gland can be divided into branches that supply central gland and that sup­ply the periphery. Based on the course, artery that supplies the central gland is termed anteromedial / superior pedicle, and artery that supplies peripheral gland is termed postero­lateral / inferior pedicle. Both often arise as a common trunk from the inferior vesical artery. Bilateral prostatic arteries are often asymmetric in origin and size. Prostatic artery is often tortuous in course, especially with enlarged prostate in BPH. Intraglandular prostatic arteries show characteristic “cork screw appearance” which helps in identication of prostatic artery during angiogram. Prostatic artery can have variable origin [16, 17]. De Assis etal. classied prostatic artery origin into four main types [19]. In Type I (28.7%), prostatic artery / inferior vesical artery arises as common ori­gin with superior vesical artery. In Type II (14.7%), prostatic artery arises from anterior division of internal iliac artery. In Type III (18.9%), prostatic artery arises from obturator artery. In Type IV (31.1%), prostatic artery arises from prox­imal internal pudendal artery. Type V includes less common origins of prostatic artery from distal internal pudendal artery, accessory internal pudendal artery, inferior gluteal artery, anterior division of internal iliac artery trifurcation or quadrifurcation, or posterior division of internal iliac artery [16, 19]. In 8%, two prostatic arteries can be seen on the single side of the pelvis [16].
25.3.10 Technique
Procedure is performed under moderate sedation. Antibiotics and non-steroidal anti-inammatory drugs can be adminis­tered during the procedure and recovery. Common femoral or radial access can be used. Transradial approach may allow early ambulation and provide better patient satisfaction. Foley’s catheter may be placed within the bladder as a land­mark to identify prostatic artery [16]. PERFECTED tech­nique of PAE is associated with better clinical outcome and lower rate of recurrence compared to previously described techniques [17]. PAE can be described in 10 steps, where steps 1 to 7 involve proximal embolization, and steps 8 to 10 describe distal embolization [17].
• Step 1: Pelvic angiogram can be performed to evaluate
pelvic vasculature. This step can be skipped if preproce-
dural MR or CT angiography has been performed.
• Step 2: Guiding catheter is placed in the internal iliac
artery, and cone beam CT angiogram, under 40 to 45
ipsilateral oblique view, is obtained to study its branches,
0
25 Interventions ofthePelvic Vessels
309
identify blood supply to prostate, and selective catheterize inferior vesical/prostatic artery.
• Step 3: After successful catheterization of inferior vesical artery using microcatheter of size 2.4F or smaller, a vaso­dilator (isosorbide mononitrate or nitroglycerine) is injected to prevent vasospasm and facilitate navigation of microcatheter.
• Step 4: Microcatheter is negotiated beyond the arterial supply to the bladder, seminal vesical, rectum, gonads, corpus cavernosum, and penis, and is placed distal within the prostatic artery before its division into superior and inferior pedicle. Cone beam CT can be performed to con­rm the catheter position within the prostatic artery and identication of non-target vessels. Non-target vessels can be selective embolized using coils or gel foam.
• Step 5: Another dose of vasodilator is administered to facilitate deposition of greater volume of embolic agent.
• Step 6: Slow injection of highly diluted microparticles or microspheres are administered using 1 ml syringe to achieve diffuse parenchyma penetration and avoid early occlusion of proximal vessel. Slow injection and limited uoroscopy are done during embolization. Polyvinyl alcohol particles and microspheres are the common embolic agents used for PAE. There is no ideal size of PVA particles that has been recommended in the litera­ture. Smaller particles achieve greater degree of ischemic of the prostate gland and reduction in serum PSA value. However, they are associated with higher chances of minor complications that include transient hematosper­mia, transient hematuria, and decreased ejaculatory vol­ume [16, 20, 21]. A study showed no signicant difference in symptomatic improvement between particle sizes of 100–300 micrometers and 300–500 micrometers [21]. Another study showed better results with use of combina­tion of both 100–300 micrometers and 300–500 microm­eters particle sizes [22].
• Step 7: When there is near stasis following proximal embolization, angiogram is taken using 1ml contrast to look for effectiveness of proximal embolization and iden­tify any collaterals.
• Step 8: Microcatheter is negotiated into intra-prostatic branches for distal embolization. Superior pedicle supply­ing central gland is embolized rst followed by inferior pedicle supplying peripheral gland. Slow DSA run is taken after successful cannulation of distal intra-prostatic vessels.
• Step 9: Slow and careful injection of additional embolic agent is done. Limited intermittent uoroscopy is used and care is taken to avoid reux and non-target emboliza­tion. Additional 30% to 100% of embolic agent can be used during distal embolization.
• Step 10: Flow stasis is conrmed. Catheter is slowly pulled back with pack back embolization of prostatic
artery till its proximal end as the catheter is pulled out. Angiogram is then taken to look for effectiveness of treat­ment, and also to look for any additional collaterals [17].
25.3.11 Complications
Prostatic artery embolization is associated with lower rates of complication. Majority of the complications are transient and include hematuria (5.6%), dysuria (9%), hematospermia (0.5%), urinary retention (7.6%), urinary tract infection (2.5%), and rectal bleeding (2.5%). Post-embolization syn­drome, characterized by irritative lower urinary tract symp­toms, pelvic pain, nausea, vomiting, and fever, is often considered as expected side effect following PAE.Prostatitis, prostatic abscess, and urosepsis can occur following PAE.Prostatic urethra can be affected by embolization; how­ever, risk of stricture is low. Non-target embolization is uncommon complication following PAE.Non-target emboli­zation can occur to bladder (cystitis, and perforation), semi­nal vesical, rectum (ischemic proctitis, and sometimes abscess and stula formation), and penis. Non-target embo­lization can be avoided by adequate preprocedural and intra­procedural evaluation of vascular anatomy, and use of prophylactic protective embolization for collateral vessels [17, 18].
25.3.12 Post-Procedural Follow-Up
Both clinical and imaging follow-up is required following PAE. Clinical and imaging assessment is generally recom­mended at 3 and 12months following PAE, and then annu­ally [17]. Clinical follow-up is based on assessment of IPSS, IIEF and QoL scores. Imaging follow-up should include ultrasound and MRI [17].
Ultrasound can be used to document improvement in both static and dynamic components of BPH. Improvement in static component of BPH is evident by decrease in size of the prostate gland. Ultrasound elastography is useful to assess the dynamic component of BPH. BPH patients have high smooth muscle tone, evident on ultrasound elastography as higher elastic modulus, or stiffness. Following PAE, there is a decrease in alpha-adrenergic receptors in embolized prostate gland, with associated decrease in smooth muscle tone and elastic modulus and stiffness of prostate gland [17].
MRI is very useful in the assessment of success following PAE. MRI protocol should include dynamic contrast enhancement and diffusion-weighted imaging. MRI is useful in the assessment of reduction in size of prostate, central gland, and median lobe [17]. MRI is useful in the identica­tion of prostatic infarction by changes in signal intensity and diffusion parameters and also identication of the lesions of
310
V. Kubihal et al.
non-target embolization [17]. Prostatic infarction is seen as T1 hyperintense, and T2 hypointense area, which with time, become isointense to rest of the central gland. High b-value diffusion-weighted images allow better identication of prostatic infarction [16, 17].
25.3.13 Outcome
Comparison of prostatic artery embolization with conven­tional surgery such as TURP and open prostatectomy can be discussed under ve major aspects. (1) At 3months follow­ up, there is no statistically signicant difference in reduction of IPSS score following PAE and conventional surgery; (2) clinical failure rates are similar; (3) complications are less with PAE; (4) duration of hospital stay is short with PAE; (5) improvement in prostate volume, post-void residual urine, and peak urine ow is lesser in PAE [17].
CIRSE (Cardiovascular and Interventional Radiological Society of Europe) dened terms such as symptomatic improvement and clinical failure to assess effectiveness of PAE. Symptomatic improvement is dened as at least 25% decrease in IPSS score, with post-procedural IPSS score of <18, and >1 decrease in QoL score with post-procedural QoL score being 3. Clinical failure is dened as less than 25% decrease in IPSS score, post-procedural IPSS score of 18% or more, 1 decrease in QoL score, post-procedural QoL score of 4 or more, or decrease in maximum urine ow rate [17].
Success rate of PAE is approximately 78% at 6 months and 75% at 12months. In patients with indwelling catheter, catheter removal following PAE is observed in 86.7% of patients. PAE is effective in treatment of refractory hematu­ria, with good results in 92% of patients at 18months follow­ up [17]. Carnevale etal. showed early clinical failure rate of
1.9% and 23% recurrence rate for lower urinary tract symp­toms at median follow-up period of 72months [20].

25.4 Varicocele Embolization

of toxic metabolites from adrenal glands, and hormonal abnormalities [24]. Patients may also present with scrotal pain or discomfort [21, 25]. Percutaneous varicocele emboli­zation is a minimally invasive alternative to surgery in patients with symptomatic varicocele or infertility.
25.4.1 Indications [22, 26]
• Infertility: Percutaneous varicocele embolization is indi­cated, if all of the following criteria are met.
– Palpable varicocele on physical examination. – The couple has known infertility. – The male partner has abnormal semen parameters or
sperm function tests.
– The female partner has normal fertility or a potentially
treatable cause of infertility.
• Testicular atrophy in pediatric or adolescent males.
• Correction of pain associated with varicoceles.
• To improve testicular function in hypogonadal men with varicocele.
25.4.2 Advantages ofPercutaneous
Embolization Over Surgery [25, 26]
• Least invasive.
• No surgical incisions.
• Often performed under local anesthesia.
• Selective venous catheterization virtually eliminates the potential damage to testicular artery.
• No or very low risk of hydrocele due to sparing of lymphatics.
• Higher technical success rate (93 to 100%) in cases with recurrence after surgery or failed surgery.
25.4.3 Contraindications (Relative)
toPercutaneous Varicocele Embolization
Varicocele is dened as abnormally dilated and tortuous pampiniform plexus of veins. It is seen in 15% of all men and ~35% of men with primary infertility [21]. In ~85% of patients, varicocele is unilateral and on the left side, and in remaining patients, the condition is bilateral. Unilateral and right-sided involvement is rare, and when present, one should exclude secondary causes such as renal mass, retroperitoneal mass, and situs inversus [2123]. Varicocele is asymptomatic in majority of the cases. Some of the patients may have pro­gressive decline in testicular function and infertility, possibly related to increased scrotal temperature, increased testicular venous pressure, hypoxia due to reduced blood ow, reux
• Severe contrast allergy
• Impaired renal function
• Coagulopathy
25.4.4 Relevant Vascular Anatomy
Spermatic vein begins at the conuence of pampiniform plexus of veins, at the root of scrotum. On the left side, it typically drains into left renal vein. On the right side, sper­matic vein typically drains into the anterolateral wall of IVC, at an acute angle, just below the right renal vein. Variations
25 Interventions ofthePelvic Vessels
311
in venous drainage of spermatic veins are common. Variable communications/collaterals with retroperitoneal veins, renal capsular veins, colic veins, and abdominal wall veins can be seen. Intercommunication between bilateral spermatic veins can exist. Identication of these collateral and selective embolization is necessary to prevent recurrence [25].
25.4.5 Preprocedural Evaluation [23, 25]
• Standard pre-angiography work-up and preparation.
• Scrotal ultrasonography should be performed with patient in both recumbent and upright position. Valsalva maneu­ver may help in engorgement of veins and documentation of reux. Documentation of reux is preferred over rigid size criteria of 2mm, as size of the veins may vary signi­cantly with hydration. Inspiratory effort, and anxiety.
• Semen analysis in male patients with infertility.
25.4.6 Technique
25.4.6.1 Anesthesia andRadiation [25]
Percutaneous varicocele embolization is often performed as a day-care procedure under local anesthesia and mild intra­venous sedation. Limited uoroscopy is used to reduce gonadal exposure. Gonadal shielding can be used, especially in young and adolescent men.
reux into spermatic vein in retrograde manner, toward the testis, especially during Valsalva maneuver.
Size of the spermatic vein should be measured, and posi­tion and size of the collaterals should be noted. Typical col­lateral pattern is seen as medial and lateral parallel divisions of spermatic vein at the level of L4 vertebral body, with medial division draining into left renal vein or IVC and lat­eral division draining into renal capsular or colonic veins. All the collateral pathways and cross-communication between bilateral spermatic vein are to be noted, as unsuccessful embolization of these collaterals may contribute to varico­cele recurrence.
25.4.6.4 Embolization [25, 27, 2931]
Choice of embolizing agent depends on the operator’s pref­erence (Fig.25.3). Liquid embolization agents with or with­out metallic coils are most commonly used in percutaneous varicocele embolization.
A. Liquid embolization agents with metallic coil
Coils of 0.035 inch or 0.038 inch are deployed at lower spermatic vein, usually at the inguinal canal. In case of dif­cult access, smaller coils (0.025 inch or 0.018 inch) are deployed using coaxial microcatheter. Oversizing by 20% of the estimated spermatic vein diameter is preferred. Two to
25.4.6.2 Venous Access [25, 27, 28]
Commonly used venous access includes right common fem­oral vein, right internal jugular vein, and basilic vein.
Femoral approach—right femoral vein is most commonly used access site. For left-sided varicocele, 7F guiding cathe­ter can be used to access left femoral vein, and coaxially introduce 4F or 5F catheter, to selectively catheterize sper­matic vein. If needed, 3F microcatheter can be used. For right-sided varicocele, reverse curve catheters such as Simmons 1 catheter can be helpful to catheterize right sper­matic vein.
Internal jugular or basilic approach—Multipurpose cath­eters can be used to selectively catheterize both the spermatic veins, usually without the need for coaxial catheters. Some authors prefer right internal jugular access for right-sided varicocele, as right spermatic vein opens at an acute angle with IVC, and forms near straight line approach from inter­nal jugular access.
25.4.6.3 Venography [25, 27]
After selective catheterization of spermatic vein ostia, veno­gram is obtained by gentle injection of contrast, with patients in reverse Trendelenburg position, or performing Valsalva maneuver. If there are incompetent valves, contrast will
Fig. 25.3 Schematic diagram of varicocele embolization using the coils
312
V. Kubihal et al.
three coils are often required for near complete occlusion of lower spermatic vein. Venogram during Valsalva maneuver is performed again, which can reveal new collaterals, due to high pressure distally occluded spermatic vein. Each of the collaterals is to be occluded directly or at its opening in sper­matic vein, using coils, if collaterals are large enough. Alternatively, liquid embolization agent can be used to occlude collaterals.
Commonly used liquid embolization agents include:
1. Sodium tetradecyl sulfate (STS) foam—3% STS is mixed
with sterile normal saline in the ratio of 2:1 to form a 2% STS solution, which is then mixed with equal quantity of air to form the STS foam. Foam is injected through the catheter in spermatic vein which is visualized by dis­placement of the previous contrast column in spermatic vein.
2. STS solution—2% STS solution is formed by mixing 3%
STS with contrast in the ratio of 2:1.
3. Glue (n-butyl cyanoacrylate)—Glue-lipiodol mixture of
ratio ranging from 1:1 to 1:6 is injected through the cath­eter after ushing the catheter with 5% dextrose solution. Glue is ushed out of the catheter by another bolus of 5% dextrose solution.
matic vein to stop the retrograde ow into renal vein or IVC, and sclerosant is injected into the spermatic vein without Valsalva maneuver. “OB technique” allows con­trolled injection of sclerosant and longer contact of scle­rosant with vessel wall.
C. Use of metallic coils or plugs alone without liquid embo-
lization agent is not preferred due to associated high recurrence rate.
25.4.7 Post-Procedural Care
Patient is discharged after observation for 2 to 4 hours. Patients can resume routine activity after 24 to 48 hours. Patients are advised to avoid strenuous activity and heavy lifting for 5 to 7 days, and to have soft high ber diet for 3days to avoid constipation. Follow-up ultrasound evalua­tion is advised at 1month and 3months following interven­tion. Although dilated veins can be seen clinically following embolization, success of procedure is determined by absence of reux into veins. Semen analysis is advised at 4 to 6months following intervention, in patients treated for infer­tility [25, 31].
Spermatic vein is occluded at inguinal canal by external pressure. Two methods of injection of liquid embolization agents can be followed.
(a) Catheter is advanced till distal spermatic vein, and liquid
embolization agent is slowly injected as the catheter is pulled back.
(b) If the catheter cannot be placed in distal spermatic vein,
liquid embolization agents can be injected from proxi­mal spermatic vein, aided by reux, during Valsalva maneuver, taking care to avoid reux into renal vein or IVC.
Liquid embolization agent is injected from the coils at inguinal canal till 1 to 2cm from the spermatic vein ostium, taking care to avoid reux into left renal vein or IVC.Often a solution of 2 to 5ml is adequate.
The last coil is used to occlude the most proximal portion of spermatic vein, without extension into renal vein or IVC.Occlusive plugs are rarely used considering high cost of the occlusive plugs.
B. Liquid embolization agents alone without coils can be
used with good results. Extra care is taken to avoid reux into pampiniform plexus of veins in scrotum, by external compression at inguinal canal, using patient’s hand or compressive device. “OB technique” is where temporary occlusive balloon catheter is placed in the proximal sper-
25.4.8 Complications
Most common complication following embolization is scro­tal pain, which is seen in nearly 17% of patients. It may per­sist up to 10 days following intervention. Other minor complications include hematoma (10%) and epididymitis (3%). There is no or very low risk of hydrocele following embolization, due to sparing of lymphatics. When seen, hydrocele may be related to thrombophlebitis associated with embolization, rather than lymphatic occlusion [23, 25].
Major complications are rare. Spermatic vein perforation is reported in up to 4.6% of patients and IVC / renal vein dis­section is reported in up to 4.1% of the cases. These compli­cations are rarely clinically signicant. Coil migration is a rare complication and can lead to renal vein thrombosis. More proximal migration can occur into IVC and pulmonary arteries. Coil migration can be prevented by accurately over­sizing the coils and use of detachable coils. Clinically sig­nicant non-target embolization following varicocele embolization with liquid embolizing agents is rare. Vicini etal. reported a case of large bowl infarction following vari­cocele sclerotherapy [23, 25].
25.4.9 Outcome
Technical success is dened as cessation of ow in spermatic vein in intraoperative post embolization imaging [25].
25 Interventions ofthePelvic Vessels
313
Percutaneous embolization is technically successful in nearly 90 to 97% of patients [23]. Meta-analysis by Cayan etal. showed technical success rate of 13.05%, irrespective of laterality [32]. Technical success depends on various fac­tors such as vascular anatomy, ease of venous access, and intra-operative factors such as vasospasm and embolizing agent used. Technical failure is rare with left-sided varico­cele embolization; however, right-sided varicocele emboli­zation can have a technical failure rate as high as 49%, often related to difcult anatomy [25].
Recurrence rate following embolization range from 0 to 24%, comparable to that of surgery [23, 25]. Newer studies show lower recurrence rate, probably related to improved oper­ator experience and varicocele embolization technique [25].
Cochrane review of 894 patients in 10 studies showed improvement in fertility and pregnancy rate following vari­cocele treatment [23]. In literature, pregnancy rate of 11 to 60% has been reported [33]. No statistically signicant dif­ference has been reported between varicocele embolization and surgery for the improvement in semen parameters and fertility [23].
Varicocele embolization is useful in relieving scrotal pain secondary to varicocele. Retrospective study of 154 patients by Puche-Sanz etal. showed that 86.9% of patients had com­plete pain relief following varicocele embolization [31].
Varicocele embolization is an ideal treatment in patients with post-surgery recurrence. Jargiello et al. reviewed 33 patients with recurrent left-sided varicocele following sur­gery and reported technical success rate of 100% with vari­cocele embolization in these patients [34].

25.5 Pelvic Congestion Syndrome

Pelvic congestion syndrome is dened as chronic pelvic pain lasting for more than 6months, associated with pelvic vari­cosities, and can increase on standing, sexual intercourse, and menstruation [35]. Up to 10% of women can have pelvic varicosities; however, only up to 40% of these women will have chronic pelvic pain / pelvic congestion syndrome [36]. Pelvic congestion syndrome typically affects young women between the age of 20 to 30years, and multiparity and hor­monal inuences are the common risk factors. It is suspected only after exclusion of more common causes of pelvic pain such as adenomyosis, endometriosis, gastrointestinal, and urological diseases [35, 37]. Several medical and surgical management are effective in the treatment of pelvic conges­tion syndrome. However, embolization of pelvic varicosities is the preferred curative treatment for patients with pelvic congestion syndrome [37].
25.5.1 Indication [38]
Embolization of pelvic varicosities is the standard treatment for patients with chronic pelvic pain and pelvic varicosities, where other causes have been excluded.
25.5.2 Contraindications [38]
• Active pelvic infection
• Pregnancy
• Prior severe contrast allergy
• Renal insufciency
• Uncorrectable coagulopathy
25.5.3 Preprocedural Evaluation
Thorough clinical evaluation and laboratory tests are con­ducted to rule out other causes of chronic pelvic pain. Pregnancy status, renal function, coagulation parameters, and complete hemogram are obtained prior to procedure [38].
Non-invasive imaging workup for pelvic congestion include transvaginal/transabdominal ultrasonography, MRI, and CT. Ultrasound is the ideal investigation for pelvic venous congestion syndrome, because of its wider availabil­ity and ability to perform dynamic imaging while standing or performing provocative maneuver. Transvaginal ultrasound with doppler evaluation is preferred over transabdominal ultrasound because pelvic veins are better visualized on transvaginal ultrasound. Criteria for diagnosis on transvagi­nal ultrasound include >4 mm dilated Para uterine vein, dilated arcuate vein in the myometrium communicating with pelvic varicosities, and slow ow (3cm/s) or reux in ovar­ian veins. Semi-upright position and provocative maneuver such as Valsalva maneuver can be performed to accentuate reux. Ultrasound has limited sensitivity in evaluation for other causes of chronic pelvic pain. MRI is the preferred investigation to rule out other causes of chronic pelvic pain because of its excellent soft tissue resolution. Time-resolved MR angiography with high temporal resolution can be used to evaluate reux in ovarian and pelvic veins. Ct has a lim­ited role in evaluation of pelvic congestion syndrome. CT can be used to rule out structural causes of venous obstruc­tion and pelvic varicosities (such as May-Thurner syndrome, nutcracker syndrome, absence of IVC, and pelvic or abdomi­nal mass), along with pelvic venous anatomy. CT criteria for pelvic varicosities include dilated para uterine vein >4mm and ovarian vein >8mm [36, 38].
314
V. Kubihal et al.
Invasive catheter-directed venogram is the gold standard for diagnosis of pelvic varicosities and venous reux. Diagnostic criteria suggested by the Society of Interventional Radiology include >5mm diameter of ovarian vein, uterine vein, or utero-ovarian arcade, reux of contrast in ovarian vein with incompetent valves, reux of contrast to contralat­eral side through utero–ovarian arcade, contras reux in vul­var or thigh veins, and stagnation of contrast in pelvic veins. Diagnostic angiogram is often reserved for patients who are planned for embolization [36, 38].
25.5.4 Relevant Vascular Anatomy
In females, pelvic venous drainage is complex with extensive collateral drainage. Internal iliac veins receive both parietal and visceral venous tributaries, including from venous plexus around uterus and vagina. Ovarian veins receive blood from gonadal venous plexus and commonly drain into left renal vein on the left side and IVC on the right side. Variations in venous drainage can be seen. Complex communication can exist between venous drainage of uterus and ovaries. Vulvar and perineal veins can drain into internal pudendal vein or circumex femoral vein. Variations in venous anatomy and collateral pathways are common and can affect success of embolization procedure [36].
25.5.5 Technique
varicosities are embolized rst, followed by other pelvic varicose veins.
Both solid (coils and vascular plugs) and liquid (glue, sclerosant) embolic agents, either alone or in combination, can be used for embolization. Choice of embolic agents depends on operator’s preference, as all of them have shown high success rate. Similar to varicocele embolization, embo­lization techniques can be (1) coil embolization with or with­out sclerosant injection; (2) sclerotherapy, more commonly with 3% sodium tetradecyl sulfate; (3) glue (n-butyl cyano­acrylate) and lipiodol injection. Following occlusion of abnormal ovarian veins, internal iliac veins with reux into visceral tributaries are embolized, commonly by balloon occluded retrograde injection of sclerosant. Balloon­occluded technique has the advantage of controlled scle­rosant injection and prevention of systemic dispersion. Technical success is dened as the absence of ow in veins that previously showed reux. All these techniques have very high technical success rate ranging from 98 to 100%. Previous studies have shown no statistically signicant dif­ference in clinical response between unilateral and bilateral embolization, when there is unilateral embolization. Rationale behind bilateral embolization was the existence of rich collateralization of bilateral pelvic veins. Percutaneous sclerotherapy can be performed for vulvar varicosities, as an adjunct procedure to catheter-directed pelvic varicosity embolization, particularly if there is incomplete response to endovascular embolization [3538].
The goal of management is to occlude pelvic veins or ovar­ian veins with spontaneous or induced reux and/or treat other vascular abnormalities responsible for pelvic conges­tion syndrome. Embolization for pelvic congestion syn­drome is often performed as the outpatient procedure. Moderate conscious sedation is recommended. Femoral or jugular/brachial venous access can be used. Jugular/brachial venous access is preferred for right ovarian vein emboliza­tion. Bilateral pelvic venogram is obtained to evaluate reux in visceral tributaries of internal iliac vein, and to look for any abnormal narrowing of common iliac vein (for example, left common iliac vein narrowing in May Thurner syn­drome). In case of signicant narrowing of common iliac vein, stenting of vein can be considered, alternative to embo­lization of internal iliac vein. After selective catheterization of left renal vein, venogram is performed to look for the pres­ence of signicant narrowing of left renal vein (for example, nutcracker syndrome) or reux into left ovarian vein. Stenting of left renal vein can be considered if signicant narrowing is identied. And if there is reux in left ovarian vein, selective left ovarian venogram is obtained to look for reux into pelvic varicosities. Most abnormal or most distal
25.5.6 Post-Procedural Care
Endovascular embolization for pelvic congestion syndrome is often a day care procedure, and the patient is discharged after hemostasis is achieved and the patient is out of seda­tion. Post-embolization syndrome is common. Patient is counseled regarding mild to moderate post-embolization pain that can last for few days. Oral pain medication such as non-steroidal anti-inammatory drugs can be prescribed. If pain is severe enough, patient can admitted overnight for pain control. Patient is advised for follow-up clinical exami­nation after 3–6 months to assess the resolution of pelvic pain. In case of persistence of symptoms, repeat imaging and embolization can be planned [36, 38].
25.5.7 Complications
Major complications are rare (complication rate—0.85 to 10%). Coil migration is rare complication and is more com­mon with internal iliac vein embolization, seen in 3–4% of patients. Coil migration can occur into left renal vein, infe-
25 Interventions ofthePelvic Vessels
315
rior vena cava, or pulmonary veins. Often migrated coils can be easily retrieved, without long-lasting complication. Risk of coil migration increases with the size of the vein emboli­zed, and is more common in vein larger than 12mm. Thirty to fty percent oversizing of coils is preferred for emboliza­tion of internal iliac vein.
Other complications include post-embolization syn­drome, mild menorrhagia, puncture site hematoma, venous perforation, and venous spasm preventing catheterization [35, 38, 39].
25.5.8 Outcome
Technical success rate for embolization for pelvic conges­tion syndrome is high, up to 98 to 100%. Symptomatic improvement is seen in 93 to 96% of patients following bilat­eral ovarian and internal iliac vein embolization and 82 to 100% of patients with bilateral ovarian vein embolization alone [35, 36].

25.6 Penile Angiography

Penile angiography and vascular interventional procedures are indicated in the treatment of high ow or non-ischemic priapism and vasculogenic erectile dysfunction from insuf­cient penile arterial ow [40, 41]. High-ow priapism occurs due to unregulated increased arterial ow to the cor­pora cavernosa of penis and is most commonly seen in the setting of trauma. Other causes include iatrogenic injury and malignant inltration. Injury to cavernosal artery or its branches can result in arterio-cavernosal stula or arterial pseudoaneurysm, with resultant increase in cavernosal blood ow and priapism. In patients not responding to conservative management (such as manual compression, ice application, or ultrasound-guided compression), cavernosal artery embo­lization can be considered [40]. Erectile dysfunction due to insufcient penile arterial ow is responsible for nearly 55% of cases of erectile dysfunction [41]. Angiographically sig­nicant penile arterial narrowing is seen in nearly 90% of patients unresponsive to phosphodiesterase therapy [41]. Endovascular penile revascularization can be useful mini­mally invasive procedure for the treatment of erectile dys­function in these cases [41].
25.6.1 Penile Vascular Anatomy
Arterial supply to the penis often arises from the internal pudendal artery, a smaller of the two terminal branches of anterior division of internal iliac artery. Internal pudendal artery exits the pelvis through the lower half of the greater
sciatic foramen, below the pyriformis muscle and then re­enters perineum through lesser sciatic foramen. On PA view, during angiography, internal pudendal artery usually over­laps the femoral head as it leaves the pelvis, which is useful in the differentiation of internal pudendal artery from supe­rior vesical artery. Internal pudendal artery gives three branches to penis, namely, deep artery of the penis (caverno­sal artery), dorsal artery of the penis (supplies glans penis) and bulbar artery (supplies corpora spongiosum and bulb). Variations in arterial supply to the penis are common. Common variations include bulbo-cavernosal artery, multi­ple cavernosal artery, and extracavernosal communication between cavernosal arteries. In nearly 25% of cases, dorsal artery and deep artery of penis can arise from accessory pudendal artery, which can arise from external iliac artery, femoral artery, obturator artery, or vesical artery [41, 42].
25.6.2 Technique
Foley’s catheter is placed with in urinary bladder, and penis is taped to contralateral thigh when angiography of internal iliac artery and internal pudendal artery is done. Common femoral artery access is most commonly used. Some authors prefer radial or brachial artery access. Pelvic angiogram can be obtained with pigtail catheter placed in the distal aorta above the bifurcation. It allows assessment of distal aorta and common and internal iliac arteries and also provide roadmap for selective catheterization of internal pudendal artery or accessory arteries supplying penis. Internal iliac artery is selectively catheterized using 4F or 5F catheter, and selective angiography is performed in 20–300 contralateral oblique view to evaluate proximal artery and 20–300 ipsilat­eral oblique view to evaluate mid and distal segment of inter­nal iliac artery [40, 41, 43].
High ow priapism: High ow priapism commonly occurs from injury to cavernosal artery or its branches with formation of arterio-cavernosal stula or cavernosal artery pseudoaneurysm. Selective catheterization of culprit artery with 2.7F microcatheter is preferred with distal emboliza­tion to avoid ischemia to the healthy tissue. Commonly used embolic agents include micro coils, polyvinyl alcohol particles, glue, or gelatin sponge slurry. Micro coils are preferred in large vessel injury, and polyvinyl alcohol par­ticles, glue, and gelatine sponge slurry are preferred when small vessel injury is present. Selective angiogram of inter­nal iliac arteries is performed to conrm complete occlu­sion and rule out accessory arterial supply to the lesion. Hemostasis is achieved. Patients are evaluated after 24 hours of procedure at discharge and at 6 weeks and 6 months following discharge by clinical evaluation and color Doppler ultrasound. Then, patients can be followed up annually [40, 43].